These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3021547)

  • 1. Follow-up of patients with epidermodysplasia verruciformis treated with etretinate.
    Jablonska S; Obałek S; Wolska H
    Dermatologica; 1986; 173(4):196-9. PubMed ID: 3021547
    [No Abstract]   [Full Text] [Related]  

  • 2. Failure of etretinate in epidermodysplasia verruciformis.
    Kowalzick L; Mensing H
    Dermatologica; 1986; 173(2):75-8. PubMed ID: 3792602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lewandowsky-Lutz epidermodysplasia verruciformis associated with vitiligo].
    Abal'iants LA; Talanin NIu
    Vestn Dermatol Venerol; 1988; (4):63-5. PubMed ID: 3414173
    [No Abstract]   [Full Text] [Related]  

  • 4. [Etretinate and the prevention of skin cancers].
    Verret JL
    Ther Umsch; 1986 Sep; 43(9):699-702. PubMed ID: 3535154
    [No Abstract]   [Full Text] [Related]  

  • 5. Epidermodysplasia verruciformis: Langerhans cells, immunologic effect of retinoid treatment and cytogenetics.
    van Voorst Vader PC; de Jong MC; Blanken R; Kallenberg CG; Vermey A; Scheres JM
    Arch Dermatol Res; 1987; 279(6):366-73. PubMed ID: 3499869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon and retinoid treatment of warts.
    Blanchet-Bardon C; Lutzner MA
    Clin Dermatol; 1985; 3(4):195-9. PubMed ID: 2463864
    [No Abstract]   [Full Text] [Related]  

  • 7. Human papillomavirus type 38 isolated from patients with epidermodysplasia verruciformis.
    Yutsudo M; Kanda R; Tanigaki T; Kitano Y; Hakura A
    Intervirology; 1986; 26(1-2):104-8. PubMed ID: 3032841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermodysplasia verruciformis. Clinical and light- and electron-microscopic observations during etretinate therapy.
    Kanerva LO; Johansson E; Niemi KM; Lauharanta J; Salo OP
    Arch Dermatol Res; 1985; 278(2):153-60. PubMed ID: 3006608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermodysplasia verruciformis: what's new?
    Jablonska S; Majewski S
    J Eur Acad Dermatol Venereol; 2003 Jul; 17(4):381-2. PubMed ID: 12834445
    [No Abstract]   [Full Text] [Related]  

  • 10. Epidermodysplasia verruciformis-associated papillomavirus infection complicating human immunodeficiency virus disease.
    Berger TG; Sawchuk WS; Leonardi C; Langenberg A; Tappero J; Leboit PE
    Br J Dermatol; 1991 Jan; 124(1):79-83. PubMed ID: 1847068
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New human papillomavirus (HPV) types involved in epidermodysplasia verruciformis (EV) in 3 HIV-infected patients: response to topical cidofovir.
    Darwich E; Darwich L; Cañadas MP; Klaustermeier J; Ercilla G; Alsina-Gibert M; Mascaró JM
    J Am Acad Dermatol; 2011 Aug; 65(2):e43-e45. PubMed ID: 21763546
    [No Abstract]   [Full Text] [Related]  

  • 12. Human immunodeficiency virus (HIV)-associated epidermodysplasia verruciformis eradicated after interferon-α and ribavirin treatment.
    Javelle E; Lightburne E; Dukan P; De Biasi C; Morand JJ
    Int J Dermatol; 2014 Apr; 53(4):487-9. PubMed ID: 24527965
    [No Abstract]   [Full Text] [Related]  

  • 13. Epidermodysplasia verruciformis.
    Jablonska S; Orth G
    Clin Dermatol; 1985; 3(4):83-96. PubMed ID: 2850863
    [No Abstract]   [Full Text] [Related]  

  • 14. Natural cell-mediated cytotoxicity against various target cells in patients with epidermodysplasia verruciformis.
    Majewski S; Malejczyk J; Jablonska S; Misiewicz J; Rudnicka L; Obalek S; Orth G
    J Am Acad Dermatol; 1990 Mar; 22(3):423-7. PubMed ID: 2155952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Types of human papillomavirus isolated from Japanese patients with epidermodysplasia verruciformis.
    Kanda R; Tanigaki T; Kitano Y; Yoshikawa K; Yutsudo M; Hakura A
    Br J Dermatol; 1989 Oct; 121(4):463-9. PubMed ID: 2560401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lewandowsky-Lutz epidermodysplasia verruciformis. Considerations on 2 cases in adults].
    Bertani E; Gasparini G; Podenzani S; Sambvani N; Guidarelli C
    G Ital Dermatol Venereol; 1983; 118(5):305-10. PubMed ID: 6321331
    [No Abstract]   [Full Text] [Related]  

  • 17. Epidermodysplasia verruciformis and generalized verrucosis: the same disease?
    Yanagi T; Shibaki A; Tsuji-Abe Y; Yokota K; Shimizu H
    Clin Exp Dermatol; 2006 May; 31(3):390-3. PubMed ID: 16681585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two human papillomavirus DNAs molecularly cloned from a patient with epidermodysplasia verruciformis: restriction maps.
    Yabe Y; Sakai A; Tanimura Y; Kuramitsu M; Hitsumoto T; Ishii K; Ueki H
    Acta Med Okayama; 1988 Aug; 42(4):243-5. PubMed ID: 2845712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe intractable common warts associated with human papillomavirus 2, 3 and 20.
    Tanigaki T; Kanda R
    Dermatologica; 1990; 181(2):159-61. PubMed ID: 2173668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermodysplasia verruciformis.
    Kawashima M
    J Dermatol; 1992 Nov; 19(11):707-9. PubMed ID: 1338070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.